| abstract |
Compositions and methods for the treatment of ophthalmic disorders, particularly preservation of corneal explants and prevention of corneal allograft rejection. These compositions comprise oligonucleotides which are specifically hybridizable with nucleic acids encoding the cellular adhesion molecules intercellular adhesion molecule-1 (ICAM-l), vascular cell adhesion molecule-l (VCAM-l) and endothelial leukocyte adhesion molecule-l (ELAM-l). |